FDA Warns Novo On Drug Contamination Measures
The U.S. Food and Drug Administration revealed Tuesday that it had sent a warning letter to Danish drugmaker Novo Nordisk A/S, accusing it of failing to properly implement anti-contamination measures at...To view the full article, register now.
Already a subscriber? Click here to view full article